These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35525960)

  • 21. Comprehensive Quality Analysis of Conventional and Novel Biomarkers in Diagnosing and Predicting Prognosis of Coronary Artery Disease, Acute Coronary Syndrome, and Heart Failure, a Comprehensive Literature Review.
    Abubakar M; Irfan U; Abdelkhalek A; Javed I; Khokhar MI; Shakil F; Raza S; Salim SS; Altaf MM; Habib R; Ahmed S; Ahmed F
    J Cardiovasc Transl Res; 2024 Jul; ():. PubMed ID: 38995611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-proteomic Biomarker Risk Scores for Predicting Risk and Guiding Therapy in Patients with Coronary Artery Disease.
    Gold ME; Woods E; Pobee D; Ibrahim R; Quyyumi AA
    Curr Cardiol Rep; 2023 Dec; 25(12):1811-1821. PubMed ID: 38079057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical applications of polygenic risk score for coronary artery disease through the life course.
    Fahed AC; Natarajan P
    Atherosclerosis; 2023 Dec; 386():117356. PubMed ID: 37931336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies.
    Martins AMA; Paiva MUB; Paiva DVN; de Oliveira RM; Machado HL; Alves LJSR; Picossi CRC; Faccio AT; Tavares MFM; Barbas C; Giraldez VZR; Santos RD; Monte GU; Atik FA
    Front Cardiovasc Med; 2021; 8():788062. PubMed ID: 35004898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course.
    Winkel P; Jakobsen JC; Hilden J; Jensen G; Kjøller E; Sajadieh A; Kastrup J; Kolmos HJ; Larsson A; Ärnlöv J; Gluud C
    Open Heart; 2018; 5(2):e000808. PubMed ID: 30228904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlations between Resting Electrocardiogram Findings and Disease Profiles: Insights from the Qatar Biobank Cohort.
    Qafoud F; Kunji K; Elshrif M; Althani A; Salam A; Al Suwaidi J; Darbar D; Asaad N; Saad M
    J Clin Med; 2024 Jan; 13(1):. PubMed ID: 38202283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk Stratification in Patients with Coronary Artery Disease: A Practical Walkthrough in the Landscape of Prognostic Risk Models.
    Buccheri S; D'Arrigo P; Franchina G; Capodanno D
    Interv Cardiol; 2018 Sep; 13(3):112-120. PubMed ID: 30443266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical inactivity and cardiac events: An analysis of the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study.
    McCarthy MM; Wackers FJT; Davey J; Chyun DA
    J Clin Transl Endocrinol; 2017 Sep; 9():8-14. PubMed ID: 29067262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomic Profiling for Diagnosis and Prognostication in Surgery: A Scoping Review.
    Khan TA; Loftus TJ; Filiberto AC; Ozrazgat-Baslanti T; Ruppert MM; Bandyopadhyay S; Laiakis EC; Arnaoutakis DJ; Bihorac A
    Ann Surg; 2021 Feb; 273(2):258-268. PubMed ID: 32482979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Heart Disease: An Intricate Interplay of a Widespread Metabolic Disorder with the Cardiovascular System.
    Shriya ASK; B Pawar V; Paul AA
    Curr Diabetes Rev; 2024 Jul; ():. PubMed ID: 38994615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of cardiac self-efficacy among patients diagnosed with coronary artery disease in tertiary hospitals in Nepal.
    Shrestha R; Rawal L; Bajracharya R; Ghimire A
    J Public Health Res; 2020 Oct; 9(4):1787. PubMed ID: 33437751
    [No Abstract]   [Full Text] [Related]  

  • 32. Defining Acute Coronary Syndrome through Metabolomics.
    Surendran A; Atefi N; Zhang H; Aliani M; Ravandi A
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study.
    Jaimes Campos MA; Andújar I; Keller F; Mayer G; Rossing P; Staessen JA; Delles C; Beige J; Glorieux G; Clark AL; Mullen W; Schanstra JP; Vlahou A; Rossing K; Peter K; Ortiz A; Campbell A; Persson F; Latosinska A; Mischak H; Siwy J; Jankowski J
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomic Insights in Risks of Developing Heart Failure: A New Frontier.
    Tang WHW
    Circ Heart Fail; 2024 Mar; 17(3):e011482. PubMed ID: 38426300
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: Novel and potential biomarkers for prediction of outcome in patients with chronic and acute coronary heart disease, volume II.
    Nilsen DWT; Kontny F; Ten Cate H
    Front Cardiovasc Med; 2024; 11():1432580. PubMed ID: 38873268
    [No Abstract]   [Full Text] [Related]  

  • 36. Pressure Never Lies, but It Should Be Interpreted Thoughtfully: The Role of Hydrostatic Pressure in Coronary Physiology.
    Kőszegi Z; Szabó GT
    J Pers Med; 2024 Mar; 14(3):. PubMed ID: 38541049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term prediction of coronary artery disease using serum metabolomic patterns.
    Petrazzini BO; Vaid A; Park JK; Marquez-Luna C; Vy HM; Saha A; Chaudhary K; Cho J; Chan L; Argulian E; Narula J; Nadkarni G; Do R
    Am Heart J Plus; 2022 Dec; 24():. PubMed ID: 36788979
    [No Abstract]   [Full Text] [Related]  

  • 38. Correction: Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers.
    Danlos FX; Grajeda-Iglesias C; Durand S; Sauvat A; Roumier M; Cantin D; Colomba E; Rohmer J; Pommeret F; Baciarello G; Willekens C; Vasse M; Griscelli F; Fahrner JE; Goubet AG; Dubuisson A; Derosa L; Nirmalathasan N; Bredel D; Mouraud S; Pradon C; Stoclin A; Rozenberg F; Duchemin J; Jourdi G; Ellouze S; Levavasseur F; Albigès L; Soria JC; Barlesi F; Solary E; André F; Pène F; Ackerman F; Mouthon L; Zitvogel L; Marabelle A; Michot JM; Fontenay M; Kroemer G
    Cell Death Dis; 2024 Feb; 15(2):142. PubMed ID: 38355585
    [No Abstract]   [Full Text] [Related]  

  • 39. Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome.
    Zhang W; Liu L; Chen H; Li S; Wan M; Mohammed AQ; Xu B; Yin G; Lv X; Shi T; Galip J; Mohammed AA; Mareai RM; Xu Y; Abdu FA; Che W
    Cardiovasc Diabetol; 2023 May; 22(1):113. PubMed ID: 37179333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the triglyceride-glucose index and severity of coronary artery disease.
    Wang X; Xu W; Song Q; Zhao Z; Meng X; Xia C; Xie Y; Yang C; Jin P; Wang F
    Cardiovasc Diabetol; 2022 Sep; 21(1):168. PubMed ID: 36050734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.